Oxford Biomedica plc (OXB.L)
GBp 425.5
(1.07%)
GBp 425.5
(1.07%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -157.49 Million GBP | -248.75% |
| 2022 | -45.15 Million GBP | -337.54% |
| 2021 | 19.01 Million GBP | 404.42% |
| 2020 | -6.24 Million GBP | 61.13% |
| 2019 | -16.06 Million GBP | -313.05% |
| 2018 | 7.54 Million GBP | 183.63% |
| 2017 | -9.01 Million GBP | 45.81% |
| 2016 | -16.64 Million GBP | -27.82% |
| 2015 | -13.01 Million GBP | -50.32% |
| 2014 | -8.66 Million GBP | 21.94% |
| 2013 | -11.09 Million GBP | -27.1% |
| 2012 | -8.73 Million GBP | 30.88% |
| 2011 | -12.63 Million GBP | -22.75% |
| 2010 | -10.29 Million GBP | -192.75% |
| 2009 | -3.51 Million GBP | 64.99% |
| 2008 | -10.04 Million GBP | 34.33% |
| 2007 | -15.28 Million GBP | 13.26% |
| 2006 | -17.62 Million GBP | -94.01% |
| 2005 | -9.08 Million GBP | 13.18% |
| 2004 | -10.46 Million GBP | 2.55% |
| 2003 | -10.73 Million GBP | 7.91% |
| 2002 | -11.66 Million GBP | -38.99% |
| 2001 | -8.38 Million GBP | -67.71% |
| 2000 | -5 Million GBP | -19.41% |
| 1999 | -4.18 Million GBP | -13.8% |
| 1998 | -3.68 Million GBP | 0.0% |
| 1997 | - GBP | 100.0% |
| 1996 | -85 Thousand GBP | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -32.48 Million GBP | 0.0% |
| 2023 FY | -157.49 Million GBP | -248.75% |
| 2023 Q2 | -47.95 Million GBP | 0.0% |
| 2023 Q4 | -109.53 Million GBP | 0.0% |
| 2022 Q2 | -25.48 Million GBP | 0.0% |
| 2022 FY | -45.15 Million GBP | -337.54% |
| 2022 Q4 | -13.67 Million GBP | 0.0% |
| 2021 FY | 19.01 Million GBP | 404.42% |
| 2021 Q2 | 18.06 Million GBP | 0.0% |
| 2021 Q4 | 942 Thousand GBP | 0.0% |
| 2020 Q2 | -6.67 Million GBP | 0.0% |
| 2020 FY | -6.24 Million GBP | 61.13% |
| 2020 Q4 | 434 Thousand GBP | 0.0% |
| 2019 FY | -16.06 Million GBP | -313.05% |
| 2019 Q2 | -10.16 Million GBP | 0.0% |
| 2019 Q4 | -5.89 Million GBP | 0.0% |
| 2018 Q4 | 2.36 Million GBP | 0.0% |
| 2018 FY | 7.54 Million GBP | 183.63% |
| 2018 Q2 | 5.18 Million GBP | 0.0% |
| 2017 Q2 | -3.34 Million GBP | 0.0% |
| 2017 FY | -9.01 Million GBP | 45.81% |
| 2017 Q4 | -5.67 Million GBP | 0.0% |
| 2016 Q4 | -7.25 Million GBP | 0.0% |
| 2016 FY | -16.64 Million GBP | -27.82% |
| 2016 Q2 | -9.38 Million GBP | 0.0% |
| 2015 Q2 | -6.12 Million GBP | 0.0% |
| 2015 Q4 | -6.89 Million GBP | 0.0% |
| 2015 FY | -13.01 Million GBP | -50.32% |
| 2014 Q4 | -3.86 Million GBP | 0.0% |
| 2014 FY | -8.66 Million GBP | 21.94% |
| 2014 Q2 | -4.8 Million GBP | 0.0% |
| 2013 Q4 | -5.23 Million GBP | 0.0% |
| 2013 FY | -11.09 Million GBP | -27.1% |
| 2013 Q2 | -5.85 Million GBP | 0.0% |
| 2012 FY | -8.73 Million GBP | 30.88% |
| 2012 Q2 | - GBP | 0.0% |
| 2012 Q4 | - GBP | 0.0% |
| 2011 FY | -12.63 Million GBP | -22.75% |
| 2011 Q4 | - GBP | 0.0% |
| 2011 Q2 | - GBP | 0.0% |
| 2010 Q4 | - GBP | 0.0% |
| 2010 FY | -10.29 Million GBP | -192.75% |
| 2010 Q2 | - GBP | 0.0% |
| 2009 Q4 | - GBP | 0.0% |
| 2009 FY | -3.51 Million GBP | 64.99% |
| 2009 Q2 | - GBP | 0.0% |
| 2008 Q4 | - GBP | 0.0% |
| 2008 FY | -10.04 Million GBP | 34.33% |
| 2008 Q2 | - GBP | 0.0% |
| 2007 Q4 | - GBP | 0.0% |
| 2007 FY | -15.28 Million GBP | 13.26% |
| 2007 Q2 | - GBP | 0.0% |
| 2006 FY | -17.62 Million GBP | -94.01% |
| 2006 Q4 | - GBP | 0.0% |
| 2006 Q2 | - GBP | 0.0% |
| 2005 Q2 | - GBP | 0.0% |
| 2005 Q4 | - GBP | 0.0% |
| 2005 FY | -9.08 Million GBP | 13.18% |
| 2004 Q2 | - GBP | 0.0% |
| 2004 FY | -10.46 Million GBP | 2.55% |
| 2004 Q4 | - GBP | 0.0% |
| 2003 Q2 | - GBP | 0.0% |
| 2003 FY | -10.73 Million GBP | 7.91% |
| 2003 Q4 | - GBP | 0.0% |
| 2002 FY | -11.66 Million GBP | -38.99% |
| 2002 Q4 | - GBP | 0.0% |
| 2002 Q2 | - GBP | 0.0% |
| 2001 FY | -8.38 Million GBP | -67.71% |
| 2000 FY | -5 Million GBP | -19.41% |
| 1999 FY | -4.18 Million GBP | -13.8% |
| 1998 FY | -3.68 Million GBP | 0.0% |
| 1997 FY | - GBP | 100.0% |
| 1996 FY | -85 Thousand GBP | 0.0% |
| Name | Net Income | Net Income Difference |
|---|